Atlas Trials

Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer

Clinical trial NCT01212822 · COMPLETED

Trial details

NCT number
NCT01212822
Sponsor
Fox Chase Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the StomachMixed Adenocarcinoma of the StomachSquamous Cell Carcinoma of the EsophagusStage IA Esophageal CancerStage IA Gastric CancerStage IB Esophageal CancerStage IB Gastric CancerStage IIA Esophageal CancerStage IIA Gastric Cancer
Start date
2011-04-27
Primary completion
2014-10-24
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.